| Recruiting | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 1 / Phase 2 | 2026-06-01 |
| Recruiting | Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Ped Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Malignant Brain Neoplasm, Resectable Brain Neoplasm | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lym Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia | Phase 1 | 2026-05-01 |
| Not Yet Recruiting | Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial Prostate Carcinoma | N/A | 2026-05-01 |
| Not Yet Recruiting | SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners Sun Protection | N/A | 2026-05-01 |
| Recruiting | A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning t Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | 2026-04-30 |
| Not Yet Recruiting | Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanom Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm, Melanoma | N/A | 2026-04-30 |
| Recruiting | Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP) Familial Adenomatous Polyposis | N/A | 2026-03-01 |
| Recruiting | A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neurop Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2026-02-23 |
| Recruiting | Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2026-01-22 |
| Recruiting | A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma | N/A | 2026-01-09 |
| Recruiting | Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer Advanced Head and Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma | Phase 2 | 2025-11-18 |
| Recruiting | Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogene Allogeneic Stem Cell Transplant | Phase 2 | 2025-10-15 |
| Recruiting | Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Hereditary Malignant Neoplasm, Hereditary Neoplastic Syndrome | N/A | 2025-09-23 |
| Recruiting | An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Neuroendocrine Tumor | EARLY_Phase 1 | 2025-09-16 |
| Recruiting | Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Ki Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Sarcomatoid Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2025-08-15 |
| Recruiting | Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer Urothelial Carcinoma | Phase 2 | 2025-07-22 |
| Recruiting | Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Sq Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8 | Phase 2 | 2025-07-17 |
| Recruiting | Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Surv Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2025-06-23 |
| Completed | Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System Genitourinary System Carcinoma, Malignant Pelvic Neoplasm | — | 2025-06-06 |
| Recruiting | Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Phase 2 | 2025-03-05 |
| Withdrawn | Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery Head and Neck Cancer | — | 2025-03-01 |
| Recruiting | SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy Metastatic Castration-Resistant Prostate Carcinoma | — | 2025-01-23 |
| Active Not Recruiting | Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Surv Anxiety | N/A | 2025-01-21 |
| Recruiting | CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer Breast Carcinoma | N/A | 2024-11-13 |
| Terminated | Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VEN Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2024-10-31 |
| Recruiting | Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients Skin Basal Cell Carcinoma | N/A | 2024-10-08 |
| Completed | Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2024-10-01 |
| Completed | Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Adolescent Cancer, Young Adult Cancer, Body Image | N/A | 2024-09-14 |
| Recruiting | Gilteritinib for the Treatment of ALK NSCLC Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 | 2024-07-25 |
| Completed | A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy Colorectal Neoplasia | EARLY_Phase 1 | 2024-06-14 |
| Suspended | A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Flud Secondary Acute Myeloid Leukemia | Phase 2 | 2024-06-03 |
| Recruiting | Breast Cancer Resiliency Through Exercise Program (B-REP) Breast Cancer Female | N/A | 2024-05-28 |
| Recruiting | Multicenter Trial of ESK981 in Patients With Select Solid Tumors Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor | Phase 2 | 2024-04-19 |
| Terminated | Cardiac Rehabilitation to Improve Breast Cancer Outcomes Breast Cancer, Cardiovascular Diseases | N/A | 2024-03-19 |
| Recruiting | Living Well With Lymphoma Lymphoma | N/A | 2024-03-07 |
| Completed | Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer Postmenopausal, Breast Cancer | N/A | 2024-03-06 |
| Withdrawn | Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype CYP3A4*22 | Phase 4 | 2024-03-01 |
| Recruiting | Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Breast Cancer | Phase 1 | 2024-02-27 |
| Recruiting | A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy Hepatocellular Carcinoma | Phase 2 | 2024-02-16 |
| Withdrawn | Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Acute Lymphoblastic Leukemia | Phase 2 | 2024-01-01 |
| Active Not Recruiting | Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer Oropharynx Cancer, HPV-Related Carcinoma | Phase 2 | 2023-12-20 |
| Recruiting | Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome | Phase 2 | 2023-12-06 |
| Recruiting | Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Pr Prostate Cancer | — | 2023-10-16 |
| Completed | Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer Thyroid Cancer | N/A | 2023-09-18 |
| Recruiting | Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Tr Hematopoietic Stem Cell Transplant | N/A | 2023-08-25 |
| Completed | Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics- Cancer | — | 2023-08-18 |
| Withdrawn | Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2023-07-01 |
| Recruiting | Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Re Chronic Lung Disease, Hematopoietic Cell Transplantation, Graft Versus Host Disease | — | 2023-05-30 |
| Recruiting | A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx | Phase 2 | 2023-04-27 |
| Recruiting | Localized Leiomyosarcoma Biomarker Protocol Leiomyosarcoma | — | 2023-04-26 |
| Recruiting | Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms T-Cell Neoplasm, Lymphoproliferative Disorders | Phase 2 | 2023-03-29 |
| Completed | Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer Patien Pediatric Cancer | N/A | 2023-02-17 |
| Recruiting | Metastatic Leiomyosarcoma Biomarker Protocol Leiomyosarcoma | — | 2022-12-22 |
| Completed | Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study Prostate Cancer | N/A | 2022-11-09 |
| Completed | The Genetic Information and Family Testing (GIFT) Study Cancer | N/A | 2022-10-24 |
| Completed | CLEAR Care Companion Application Bladder Cancer, Radical Cystectomy | N/A | 2022-08-12 |
| Completed | Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) Melanoma, Ocular, Melanoma, Cutaneous, Metastatic Melanoma | Phase 1 | 2022-08-09 |
| Completed | Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid Breast Cancer | N/A | 2022-05-12 |
| Completed | Michigan Genetic Hereditary Testing (MiGHT) Breast Cancer, Colorectal Cancer, Ovarian Cancer | N/A | 2022-04-21 |
| Recruiting | Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer Breast Cancer, Metastatic Gastric Cancer, Esophageal Cancer | Phase 4 | 2022-03-28 |
| Completed | Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study Breast Cancer, Gynecologic Cancer | N/A | 2022-03-15 |
| Completed | Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging Gynecologic Cancer | N/A | 2022-01-05 |
| Recruiting | Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Prostate Cancer | Phase 2 | 2021-11-12 |
| Completed | An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Breast Cancer Survivorship, Cancer-related Cognitive Impairment | N/A | 2021-10-26 |
| Terminated | Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First- Advanced Adult Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2021-08-06 |
| Completed | Lighting Intervention for Cancer-related Fatigue Breast Cancer, Prostate Cancer, Hematologic Malignancy | N/A | 2021-07-15 |
| Completed | Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living Ovarian Cancer | N/A | 2021-06-28 |
| Completed | Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhib Solid Tumor | EARLY_Phase 1 | 2021-06-02 |
| Active Not Recruiting | Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towa Prostate Cancer, Castrate Sensitive Prostate Cancer, Oligometastatic Disease | Phase 2 | 2021-05-28 |
| Active Not Recruiting | Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer Prostate Cancer Metastatic, Neuroendocrine Tumors | Phase 2 | 2021-05-25 |
| Completed | Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors Insomnia, Breast Cancer, Prostate Cancer | N/A | 2021-05-12 |
| Completed | Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias Arthralgia, Breast Cancer | Phase 2 | 2021-04-16 |
| Terminated | Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions | N/A | 2021-03-26 |
| Terminated | Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program Cancer | N/A | 2021-03-25 |
| Completed | Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prost Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma | Phase 1 | 2021-03-04 |
| Terminated | Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients Gynecologic Cancer | Phase 3 | 2020-12-28 |
| Terminated | Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients Depression, Anxiety, Cancer | N/A | 2020-11-30 |
| Active Not Recruiting | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereot Prostate Cancer | Phase 1 / Phase 2 | 2020-11-06 |
| Active Not Recruiting | Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Ri Prostate Cancer | N/A | 2020-11-05 |
| Active Not Recruiting | Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Glioblastoma | Phase 2 | 2020-11-04 |
| Completed | Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors Neuroendocrine Tumors | EARLY_Phase 1 | 2020-10-19 |
| Active Not Recruiting | Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Mu Multiple Myeloma | Phase 2 | 2020-10-05 |
| Withdrawn | Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer Prostate Cancer | Phase 2 | 2020-10-01 |
| Completed | A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients Cancer, Quality of Life | N/A | 2020-09-18 |
| Recruiting | Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) Liver Malignancy | Phase 1 | 2020-09-16 |
| Completed | Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation Hematologic Diseases | N/A | 2020-09-08 |
| Terminated | Testing the Effect of Mindfulness for Prostatectomy Outcomes Prostate Cancer | N/A | 2020-08-26 |
| Active Not Recruiting | Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV | Phase 1 | 2020-08-05 |
| Completed | Altering Lipids for Tolerance of Aromatase Inhibitor Therapy Breast Cancer | Phase 2 | 2020-07-28 |
| Withdrawn | Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2020-07-01 |
| Terminated | Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectabl Biliary Tract Cancer | Phase 1 / Phase 2 | 2020-06-23 |
| Terminated | Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunothe Indolent Lymphoma | Phase 1 | 2020-06-15 |
| Completed | Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma Sarcoma, Sarcoma Metastatic | Phase 2 | 2020-03-17 |
| Active Not Recruiting | Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogenei Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase | Phase 1 / Phase 2 | 2020-02-04 |
| Withdrawn | Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma Glial Tumor of Brain, Diffuse Intrinsic Pontine Glioma, Glioma | EARLY_Phase 1 | 2019-11-30 |
| Active Not Recruiting | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) Prostate Cancer | Phase 2 | 2019-10-31 |
| Active Not Recruiting | APG-115 in Salivary Gland Cancer Trial Malignant Salivary Gland Cancer, Salivary Gland Cancer | Phase 1 / Phase 2 | 2019-10-28 |
| Completed | Acupressure for Fatigue in Ovarian Cancer Survivors Fatigue, Ovarian Cancer | N/A | 2019-10-07 |
| Withdrawn | A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas Glioma, Diffuse Intrinsic Pontine Glioma | Phase 2 | 2019-10-01 |
| Completed | Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer Oropharynx Squamous Cell Carcinoma | Phase 2 | 2019-09-05 |
| Recruiting | Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas Colonic Neoplasms | — | 2019-08-07 |
| Completed | Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface Post-Mastectomy Chronic Pain Syndrome | N/A | 2019-07-12 |
| Terminated | ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer Prostate Cancer | Phase 1 | 2019-05-31 |
| Completed | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary T Biliary Tract Cancer | Phase 1 / Phase 2 | 2019-05-22 |
| Terminated | Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia | Phase 1 | 2019-05-15 |
| Completed | Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed Peripheral T Cell Lymphoma | Phase 2 | 2019-04-25 |
| Terminated | Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma Renal Cell Carcinoma, Metastatic | Phase 2 | 2019-04-11 |
| Completed | Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Biliary Tract Cancer | Phase 2 | 2019-03-28 |
| Terminated | Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2018-12-24 |
| Completed | Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor | Phase 2 | 2018-12-14 |
| Completed | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) Prostate Cancer | Phase 2 | 2018-12-10 |
| Terminated | Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer Prostate Cancer | Phase 2 | 2018-11-13 |
| Completed | The ConnectedCancerCare Pilot Study (CCC) Early-stage Breast Cancer, Breast Cancer Female, Survivorship | N/A | 2018-08-08 |
| Terminated | Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Und Glioblastoma | — | 2018-07-05 |
| Completed | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Cancer | N/A | 2018-06-13 |
| Completed | Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer Oropharynx Cancer | Phase 2 | 2018-05-21 |
| Terminated | Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 2 | 2018-03-05 |
| Withdrawn | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma Cutaneous T Cell Lymphoma | EARLY_Phase 1 | 2018-03-01 |
| Completed | Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer Urothelial Carcinoma | Phase 2 | 2018-02-08 |
| Terminated | Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma Urothelial Carcinoma | Phase 2 | 2018-01-24 |
| Withdrawn | A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML Leukemia, Chronic Myeloid | Phase 1 / Phase 2 | 2018-01-01 |
| Terminated | Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab Myelodysplastic Syndromes, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | 2017-12-21 |
| Completed | The SMART CART Study: Health Information Technology Leukemia, Acute, Leukemia, Lymphoblastic | N/A | 2017-12-20 |
| Terminated | Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platele Glioma, High Grade Glioma, Pontine Tumors | Phase 2 | 2017-12-06 |
| Terminated | Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Pr Urothelial Carcinoma | EARLY_Phase 1 | 2017-11-01 |
| Completed | Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unr Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2017-10-12 |
| Completed | Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Age Non-small Cell Lung Cancer | Phase 2 | 2017-10-03 |
| Completed | Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresect Biliary Tract Neoplasms | Phase 2 | 2017-09-08 |
| Completed | Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Ca Breast Cancer | Phase 1 | 2017-07-26 |
| Withdrawn | Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolizatio Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2017-07-01 |
| Completed | The Validation of a Novel Adherence Method for Oral Oncolytics Cancer | N/A | 2017-06-20 |
| Withdrawn | Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Loca Carcinoma, Hepatocellular | N/A | 2017-05-11 |
| Recruiting | Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer Metastatic Thyroid Cancer | Phase 2 | 2017-04-27 |
| Completed | Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients Hematopoietic Stem Cell Transplantation | Phase 2 | 2017-04-26 |
| Completed | Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer Prostate Cancer | Phase 1 | 2017-03-27 |
| Completed | Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cel Renal Cell Carcinoma | Phase 1 / Phase 2 | 2017-03-16 |
| Completed | Functional Imaging in Lung SBRT Lung Cancer | — | 2017-02-06 |
| Completed | Genomics in Michigan Impacting Observation or Radiation Prostate Cancer | N/A | 2017-01-17 |
| Completed | Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Oropharyngeal Squamous Cell Cancer | Phase 2 | 2016-10-31 |
| Withdrawn | Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Sm Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic | Phase 1 / Phase 2 | 2016-10-01 |
| Completed | A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Gliobla Glioma | Phase 2 | 2016-09-22 |
| Completed | Expansion Trial for Axitinib In Head And Neck Cancer Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2016-08-30 |
| Completed | Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma Carcinoma, Renal Cell | EARLY_Phase 1 | 2016-06-01 |
| Completed | Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin | Phase 1 | 2016-05-12 |
| Terminated | Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer Breast Cancer, Insomnia | N/A | 2016-03-16 |
| Completed | Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Trans Malnutrition, Obesity | — | 2016-03-09 |
| Completed | A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome Hemophagocytic Syndrome (HPS) | Phase 2 | 2016-02-05 |
| Terminated | Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy Head and Neck Neoplasms | Phase 2 | 2016-02-01 |
| Completed | A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma Hepatocellular Carcinoma | N/A | 2016-01-26 |
| Completed | A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Carcinoma, Non-Small-Cell Lung | N/A | 2016-01-14 |
| Completed | Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap" Patients Undergoing Bone Marrow Transplant (BMT) | N/A | 2016-01-14 |
| Withdrawn | Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma Lymphoma | Phase 1 / Phase 2 | 2015-12-01 |
| Completed | A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC Non-small Cell Lung Cancer | EARLY_Phase 1 | 2015-10-01 |
| Completed | Early Imaging Biomarkers in NSCLC Thoracic Cancer | — | 2015-09-23 |
| Completed | A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers Leukemia, Lymphoma, Brain Tumor | N/A | 2015-09-01 |
| Withdrawn | Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Ad Non-Small Cell Lung Cancer | EARLY_Phase 1 | 2015-09-01 |
| Completed | VISmodegib for ORbital and Periocular Basal Cell Carcinoma Carcinoma, Basal Cell | Phase 4 | 2015-07-15 |
| Completed | Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherap Breast Cancer | — | 2015-06-01 |
| Completed | Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma Multiple Myeloma | Phase 2 | 2015-06-01 |
| Active Not Recruiting | The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) Breast Neoplasms | N/A | 2015-05-27 |
| Completed | Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leu Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2015-01-01 |
| Recruiting | Quantitative MRI for Myelofibrosis Myelofibrosis | — | 2014-12-22 |
| Completed | Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Trans Graft vs Host Disease, Hematologic Neoplasms, Non-Neoplastic Hematologic and Lymphocytic Disorder | Phase 2 | 2014-12-01 |
| Completed | Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies Hematologic Malignancies, Relapse, Graft-Versus-Host Disease | Phase 1 / Phase 2 | 2014-10-01 |
| Completed | Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lym Lymphoma, T-Cell | Phase 2 | 2014-09-01 |
| Completed | A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostat Prostate Cancer | Phase 2 | 2014-06-01 |
| Terminated | Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma Renal Cell Carcinoma | N/A | 2014-05-01 |
| Completed | Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients Breast Cancer | — | 2014-05-01 |
| Terminated | Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery Metastatic Melanoma, Brain Metastases | Phase 2 | 2014-04-01 |
| Completed | Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma Malignant Glioma, Glioblastoma Multiforme | Phase 1 | 2014-04-01 |
| Withdrawn | A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management C Head and Neck Cancer | N/A | 2014-03-01 |
| Completed | Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2014-02-01 |
| Completed | Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas Adenocarcinoma of the Pancreas | Phase 1 / Phase 2 | 2014-01-01 |
| Withdrawn | A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer Cancer of Head and Neck | Phase 2 | 2013-12-01 |
| Completed | Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain Pain | Phase 2 | 2013-10-30 |
| Withdrawn | RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease. Chronic Myeloid Leukemia | Phase 1 / Phase 2 | 2013-09-01 |
| Terminated | Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer Metastatic Breast Cancer | — | 2013-08-01 |
| Completed | A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease Graft vs Host Disease | Phase 2 | 2013-07-01 |
| Terminated | A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Ther Brain Tumor, Primary | N/A | 2013-06-01 |
| Completed | Optimization of MRI for Radiation Therapy Cancer Liver, Cancer Brain, Cancer Head &Neck | — | 2013-03-14 |
| Withdrawn | Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer Urothelial Cancer, Bladder Cancer | Phase 2 | 2012-11-01 |
| Completed | A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated Relapsed Chronic Lymphocytic Leukemia | Phase 2 | 2012-11-01 |
| Terminated | Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer Prostate Cancer | Phase 1 | 2012-10-01 |
| Completed | Effect of Radiation on Tissue for Delayed Breast Reconstruction Breast Cancer | N/A | 2012-10-01 |
| Terminated | Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) Urothelial Cancer, Bladder Cancer | Phase 2 | 2012-09-01 |
| Completed | A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2012-07-01 |
| Completed | Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Laryngeal Cancer | Phase 2 | 2012-03-01 |
| Terminated | Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone Prostate Cancer Metastatic | Phase 2 | 2012-02-01 |
| Completed | Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer Head and Neck Squamous Cell Carcinoma | Phase 2 | 2012-01-01 |
| Completed | Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer Breast Cancer | Phase 1 | 2012-01-01 |
| Completed | A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Contro Pancreatic Cancer | — | 2012-01-01 |
| Completed | Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen Acute Myeloblastic Leukemia | Phase 2 | 2011-11-01 |
| Completed | Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | Phase 2 | 2011-10-01 |
| Terminated | Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymp Follicular Lymphoma | Phase 2 | 2011-07-01 |
| Completed | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers Pancreatic Cancer, Biliary Cancer | Phase 2 | 2011-07-01 |
| Completed | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients Pancreatic Cancer | Phase 2 | 2011-06-01 |
| Terminated | A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | — | 2011-05-01 |
| Completed | Hypofractionated Stereotactic Body Radiation Therapy (SBRT) Prostate Cancer | Phase 2 | 2011-01-01 |
| Completed | Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients Squamous Cell Carcinoma of the Oropharynx, HPV | N/A | 2011-01-01 |
| Terminated | Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients Nausea, Vomiting, Terminally Ill | Phase 2 | 2010-11-01 |
| Terminated | A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 2 | 2010-06-01 |
| Completed | Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy Head and Neck Squamous Cell Carcinoma | N/A | 2010-01-01 |
| Terminated | Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Can Urothelial Cancer, Bladder Cancer | Phase 2 | 2009-10-01 |
| Completed | A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer Liver Cancer, Hepatocellular Cancer | Phase 2 | 2009-10-01 |
| Completed | Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Multiple Myeloma | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer Breast Cancer, Arthralgia, Obesity | — | 2009-09-01 |
| Completed | Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients Breast Cancer, Pain, Arthralgia | — | 2009-07-01 |
| Terminated | Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treate Chronic Myeloid Leukemia | — | 2009-05-01 |
| Terminated | Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcin Head and Neck Cancer | Phase 2 | 2009-04-01 |
| Completed | Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Pro Graft Versus Host Disease | Phase 2 | 2009-03-01 |
| Completed | Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study Breast Cancer | — | 2009-03-01 |
| Completed | A Study Using Cone Beam CT for Head and Neck Cancer Head and Neck Cancer | N/A | 2009-01-01 |
| Completed | Trial Of Double Umbilical Cord Blood Transplantation Hematological Malignancies | Phase 2 | 2008-12-01 |
| Terminated | Phase I/II Calcitriol in Lung Cancer Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2008-12-01 |
| Completed | Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Assoc Breast Cancer | N/A | 2008-10-01 |
| Completed | A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tom Hepatocellular Carcinoma | — | 2008-08-01 |
| Completed | A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma Osteosarcoma | Phase 2 | 2008-08-01 |
| Completed | Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | N/A | 2008-08-01 |
| Terminated | Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2008-07-01 |
| Completed | Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2008-05-01 |
| Completed | The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease Acute Graft Versus Host Disease | Phase 3 | 2008-05-01 |
| Completed | A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response Pancreatic Cancer | — | 2008-05-01 |
| Completed | Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma Neuroblastoma | Phase 1 | 2008-04-01 |
| Completed | Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer Metastatic Breast Cancer | Phase 1 / Phase 2 | 2008-03-01 |
| Terminated | A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 1 | 2008-03-01 |
| Completed | Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer Bladder Cancer | Phase 2 | 2008-03-01 |
| Terminated | Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Multiple Myeloma, Plasma Cell Leukemia | Phase 2 | 2008-02-01 |
| Completed | Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer Bladder Cancer | Phase 2 | 2007-12-01 |
| Completed | Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2007-10-01 |
| Terminated | Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia Chronic Myeloid Leukemia | Phase 2 | 2007-09-01 |
| Completed | Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC Extensive-Stage Small Cell Lung Cancer | Phase 2 | 2007-09-01 |
| Terminated | Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure Breast Cancer | Phase 2 | 2007-08-01 |
| Terminated | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy ( Cancer of Larynx | Phase 2 | 2007-08-01 |
| Terminated | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma Loco-regional Esophageal Cancer | Phase 2 | 2007-06-01 |
| Completed | Early Assessment of Treatment Response Using Functional Diffusion Mapping Prostate Cancer | N/A | 2007-05-01 |
| Completed | Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer Non-Small Cell Lung Cancer | — | 2007-05-01 |
| Terminated | Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Maligna Non-Small-Cell Lung Carcinoma, Prostate Cancer, Bladder Cancer | Phase 1 | 2007-04-01 |
| Completed | Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2007-04-01 |
| Completed | Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia Acute Myelogenous Leukemia | Phase 2 | 2007-03-01 |
| Terminated | Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy Prostate Cancer | Phase 2 | 2007-03-01 |
| Completed | A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion Liver Cancer | — | 2007-03-01 |
| Terminated | Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma Diffuse Large B Cell Lymphoma | — | 2006-11-01 |
| Terminated | A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Metastatic Pancreatic Carcinoma | Phase 1 | 2006-10-01 |
| Completed | A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation Sarcoma, Neuroblastoma, Wilm's Tumor | Phase 2 | 2006-06-01 |
| Completed | Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy Breast Cancer | EARLY_Phase 1 | 2006-06-01 |
| Completed | Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2006-06-01 |
| Terminated | Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma Bladder Cancer | Phase 2 | 2006-05-01 |
| Completed | Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Can Head and Neck Cancer | N/A | 2006-04-01 |
| Completed | A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer Postmenopausal Bone Loss, Breast Cancer | — | 2006-04-01 |
| Completed | A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2006-04-01 |
| Terminated | A Study of Mitomycin C, Irinotecan, and Cetuximab Colorectal Cancer | Phase 2 | 2005-12-01 |
| Terminated | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus | Phase 2 | 2005-10-01 |
| Completed | Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2005-10-01 |
| Completed | Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma Multiple Myeloma | Phase 2 | 2005-08-01 |
| Completed | Treatment for Patients With Metastatic Thyroid Cancer Thyroid Cancer | Phase 2 | 2005-07-01 |
| Completed | Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer Prostate Cancer | Phase 2 | 2005-07-01 |
| Completed | Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas Sarcoma | Phase 2 | 2005-06-01 |
| Completed | Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma Multiple Myeloma | Phase 2 | 2005-06-01 |
| Completed | Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer Breast Cancer | — | 2005-05-01 |
| Completed | Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Ca Metastatic Breast Cancer | — | 2005-04-01 |
| Completed | MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and Af Brain Metastases | — | 2005-04-01 |
| Terminated | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Advanced Non-Small Cell Lung Cancer | Phase 2 | 2004-12-01 |
| Completed | Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation Hepatic Irradiation | — | 2004-11-24 |
| Completed | Vessel Sparing Prostate Radiation Therapy Cancer of the PROSTATE | Phase 2 | 2004-11-01 |
| Terminated | Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy Breast Cancer | Phase 2 | 2004-11-01 |
| Completed | MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier Brain Neoplasms | — | 2004-08-26 |
| Completed | Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sar Sarcoma, Soft Tissue | Phase 2 | 2004-08-01 |
| Completed | Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation Graft-Versus-Host Disease | Phase 2 | 2004-08-01 |
| Completed | Computer-Based Tailored or Standard Information for Colorectal Cancer Screening Colorectal Cancer | — | 2004-08-01 |
| Completed | Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma Multiple Myeloma | N/A | 2004-07-01 |
| Completed | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer Pancreatic Neoplasms | Phase 1 / Phase 2 | 2004-06-01 |
| Terminated | Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma Thyroid Cancer | Phase 2 | 2004-02-01 |
| Completed | Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Tran Lung Injury, Acute, Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans | Phase 2 | 2003-10-01 |
| Completed | The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease Graft-Versus-Host Disease | Phase 2 | 2003-10-01 |
| Completed | Optimized Intensity Modulated Irradiation for Head and Neck Cancer Head and Neck Cancer | N/A | 2003-08-01 |
| Completed | Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine Breast Cancer | N/A | 2003-07-01 |
| Completed | Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2003-06-01 |
| Completed | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | 2003-05-01 |
| Completed | Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade | Phase 2 | 2003-04-01 |
| Terminated | Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin's | Phase 2 | 2003-03-01 |
| Completed | Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer Prostate Cancer | Phase 2 | 2003-03-01 |
| Completed | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2003-03-01 |
| Terminated | Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage Breast Cancer | — | 2003-01-01 |
| Completed | A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2002-11-01 |
| Completed | Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate Hormone-Refractory Prostate Cancer | Phase 2 | 2002-04-01 |
| Completed | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive Small Cell Lung Cancer | Phase 2 | 2002-03-01 |
| Completed | Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2001-12-01 |
| Terminated | Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer Pancreatic Cancer | N/A | 2001-12-01 |
| Completed | Curcumin for the Prevention of Colon Cancer Colorectal Cancer | Phase 1 | 2001-12-01 |
| Completed | Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma Esophageal Carcinoma | Phase 2 | 2001-11-01 |
| Completed | Tetrathiomolybdate in Hormone Refractory Prostate Cancer Prostate Cancer | Phase 2 | 2001-05-01 |
| Terminated | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site Carcinoma of Unknown Primary | Phase 2 | 2001-05-01 |
| Completed | Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin's | Phase 2 | 2001-04-01 |
| Completed | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma Colorectal Carcinoma | Phase 2 | 2001-02-01 |
| Completed | Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 2 | 2000-10-01 |
| Terminated | Radiation Therapy With Capecitabine in Rectal Cancer Rectal Cancer | Phase 2 | 2000-10-01 |
| Completed | Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer Urologic Neoplasms | Phase 2 | 2000-09-01 |
| Completed | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer Breast Cancer, Colorectal Cancer, Esophageal Cancer | — | 2000-06-01 |
| Completed | Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood Myeloma, Plasma-Cell, Lymphoma, Malignant, Myeloproliferative Disorders | Phase 2 | 2000-03-01 |
| Terminated | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine Metastatic Colorectal Cancer | Phase 2 | 2000-03-01 |
| Terminated | Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood Leukemia, Lymphoma, Low-Grade, Lymphoma, Non-Hodgkin's | Phase 2 | 2000-03-01 |
| Completed | Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of Bladder Cancer | Phase 2 | 1999-11-01 |
| Completed | Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 1999-03-01 |
| Completed | UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer HER-2 Positive Metastatic Breast Cancer | Phase 2 | 1999-03-01 |
| Completed | UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia Cervical Cancer, Precancerous/Nonmalignant Condition | N/A | 1999-01-01 |
| Completed | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate Prostate Cancer | Phase 2 | 1998-12-01 |
| Completed | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma Esophageal Cancer | Phase 2 | 1997-11-01 |
| Completed | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers Wilms Tumor, Fibrosarcoma, Carcinoma, Round Cell | Phase 2 | 1997-01-01 |
| Completed | Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus Esophageal Cancer | Phase 2 | 1995-10-01 |
| Withdrawn | A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma Squamous Cell Carcinoma, Head And Neck | Phase 2 | — |
| Terminated | Companion Pharmacogenetic Study to UMCC 9900/9901 Metastatic Breast Cancer | — | — |